Connect with us

Hi, what are you looking for?

Jewish Business News

VC, Investments

SaaS co Clarizen raises $35 million

Goldman Sachs & Co. led the Series F investment round.

 Clarizen Inc. SaaS company, an enterprise work collaboration software,  has raised a $35 million financing F round led by Goldman Sachs & Co. This investment round brings Clarizen’s total funding to date to $90 million.

All existing investors also participated in the round, including Benchmark Capital, Carmel Ventures, DAG Ventures, Opus Capital, and Vintage Investment Partners. The company will use this latest funding round to expand global market share, focusing on customer success, including onboarding and support, and continuing product innovation to support the enterprise market.

Founded in 2006 by its CEO Avinoam Nowogrodski, Clarizen has more than 2, 000 customers in 76 countries, recently reported nearly 100% quarter-over-quarter growth and the addition of 230 customers, including Electronic Arts, Sony and one of the Big Four audit firms.

Clarizen CEO Avinoam Nowogrodski said, “Enterprise work collaboration is transforming the way global organizations succeed and Clarizen is leading enterprises into 21st century decision-making and execution.” “Unlike other SaaS companies that focus primarily on selling to a functional department within organizations, Clarizen targets all employees wall-to-wall across enterprises, which suggests the magnitude of the opportunity. Clarizen’s opportunity is across verticals, across geographies, across functional departments, and across customer segments, ” said Michael Huang, Senior Research Analyst – SaaS/Application Software, in a recent Needham and Company report.

Clarizen has offices in San Mateo California and in Israel.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


Now Platika joins and elite club of $10 billion plus Israeli firms.